NATCOPHARM.NS

NATCO Pharma Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$863.90

Jun 12, 2026

AI Brief

Market cap

$154.73B

52w range

—

P / E

—

EPS · FY 2026

$79.21

Volume

—

Revenue · FY 2026

$40.78B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on NATCO Pharma Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$863.90

Change

+5.64%

Period high

$1206.00

Period low

$817.80

Period start

$817.802026-02-01

Through 2026-06-12

Fair value

Football field →

Weighted blend

$1,764.59

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for NATCOPHARM.NS.

Peers

No peer list available for NATCOPHARM.NS.

Total assets

$110.74B

Total debt

$7.14B

Cash & equiv

$1.99B

Operating CF

$17.68B

Free cash flow

$13.77B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$40.78B	$12.3B	$14.19B	$79.21	+34.78%